Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Propranolol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 known ✓ | P07550 | 8/20 | 0.97 |
| ▸ | ADRB1 known ✓ | P08588 | 7/20 | 0.97 |
| ▸ | ADRB3 | P13945 | 6/20 | 0.97 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.97 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.97 |
| ▸ | HTR2C | P28335 | 4/20 | 0.97 |
| ▸ | LMNA | P02545 | 4/20 | 0.97 |
| ▸ | HTR1A | P08908 | 4/20 | 0.97 |
| ▸ | HTR2A | P28223 | 3/20 | 0.97 |
| ▸ | HTR6 | P50406 | 3/20 | 0.97 |
| ▸ | TSHR | P16473 | 3/20 | 0.97 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.97 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.97 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.97 |
| ▸ | BLM | P54132 | 2/20 | 0.97 |
| ▸ | TMEM97 | Q5BJF2 | 2/20 | 0.97 |
| ▸ | APEX1 | P27695 | 1/20 | 0.97 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.97 |
| ▸ | CYP2D6 | P10635 | 6/20 | 0.95 |
| ▸ | NR2E1 | Q9Y466 | 5/20 | 0.95 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propranolol SCHEMBL17838091 | 0.99 | ADRB2 (1.00) | ADRB2ADRB1ADRB3SIGMAR1ALDH1A1 | |
| Propranolol SCHEMBL29349844 | 0.99 | ADRB2 (1.00) | ADRB2ADRB1ADRB3SIGMAR1ALDH1A1 | |
| Levopropranolol SCHEMBL30530984 | 0.99 | ADRB2 (1.00) | ADRB2ADRB1ADRB3SIGMAR1ALDH1A1 | |
| Propranolol SCHEMBL41688 | 0.99 | ADRB2 (1.00) | ADRB2ADRB1ADRB3SIGMAR1ALDH1A1 | |
| Levopropranolol SCHEMBL41689 | 0.99 | ADRB2 (1.00) | ADRB2ADRB1ADRB3SIGMAR1ALDH1A1 | |
| Propranolol SCHEMBL9064508 | 0.99 | ADRB2 (1.00) | ADRB2ADRB1ADRB3SIGMAR1ALDH1A1 | |
| Propranolol SCHEMBL1553064 | 0.99 | ADRB2 (1.00) | ADRB2ADRB1ADRB3SIGMAR1ALDH1A1 | |
| Dexpropranolol SCHEMBL30309315 | 0.99 | ADRB2 (1.00) | ADRB2ADRB1ADRB3SIGMAR1ALDH1A1 | |
| Propranolol SCHEMBL20487330 | 0.99 | ADRB2 (0.97) | ADRB2ADRB1ADRB3SIGMAR1ALDH1A1 | |
| Dexpropranolol SCHEMBL610656 | 0.99 | ADRB2 (1.00) | ADRB2ADRB1ADRB3SIGMAR1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0585440-B1 | 2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALENE DERIVATIVES ACTIVE ON THE CARDIOVASCULAR SYSTEM, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ZAMBON SPA (IT) | 1996-05-08 | — | — | EP | disclosed |
| US-5407956-A | Hypotensive agents, kidney disorders | ZAMBON GROUP S.P.A. (IT) | 1995-04-18 | — | — | US | disclosed |
| EP-0585440-A1 | 2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALENE DERIVATIVES ACTIVE ON THE CARDIOVASCULAR SYSTEM, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | ZAMBON SPA (IT) | 1994-03-09 | — | — | EP | disclosed |
| WO-1993019036-A1 | 2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALENE DERIVATIVES ACTIVE ON THE CARDIOVASCULAR SYSTEM, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ZAMBON GROUP S.P.A. (IT) | 1993-09-30 | — | — | WO | disclosed |